Samsung SDS has taken a top spot in the 2020 iDASH Secure Genome Analysis Competition. The company was specifically recognized for its homomorphic encryption technology, which is able to analyze and process encrypted data without needing to decrypt it first. Since that data is not decrypted, it is less likely to be exposed, making homomorphic encryption an effective approach to the protection of sensitive personal information.
At iDASH, Samsung SDS was one of the 36 teams competing in the competition’s ‘Secure Multi-label Tumor Classification Using Homomorphic Encryption’ track. Those teams were given the genome variation data of roughly 2,700 people, and were asked to build a classification model that would allow them to predict the classes of tumor for 900 people whose data had been homomorphically encrypted. Samsung SDS posted high scores for analysis speed and analysis accuracy, and was part of a four-way tie for first place alongside Seoul National University and two other security companies.
“The global competition proved Samsung SDS’s superior homomorphic encryption technology,” said Samsung SDS SVP and Technology Research Leader Sang-wook Lee. “We will continue advancing the technology and apply it to a wider range of industries.”
Samsung started researching homomorphic encryption in 2018. The technology is now being used for a number of sensitive applications, including credit rating analysis in the financial industry and disease diagnostics in the healthcare industry.
In March, Samsung SDS received NIAP certification for its Enterprise Mobility Management solution. The company has also partnered with Syniverse in an effort to develop a universal mobile wallet that will facilitate mobile payments with blockchain technology.